Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor flk1

MLA

Becker, Cm, et al. Gene Therapy of Prostate Cancer with the Soluble Vascular Endothelial Growth Factor Receptor Flk1. 2002. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234793871&authtype=sso&custid=ns315887.

APA

Becker, C., Farnebo, F., Iordnanescu, I., Behonick, D., Shih, M., Dunning, P., Christofferson, R., Mulligan, R., Taylor, G., Kuo, C., & Zetter BR. (2002). Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor flk1.

Chicago

Becker, Cm, Fa Farnebo, I Iordnanescu, Dj Behonick, Mc Shih, P Dunning, R Christofferson, et al. 2002. “Gene Therapy of Prostate Cancer with the Soluble Vascular Endothelial Growth Factor Receptor Flk1.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234793871&authtype=sso&custid=ns315887.